XML 29 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Fair Value Measurements

11. Fair Value Measurements

The Company determines the fair values of its financial instruments based upon the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Below are the three levels of inputs that may be used to measure fair value:

 

•   Level 1—Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

 

•   Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

•   Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company uses the market approach technique to value its financial instruments and there were no changes in valuation techniques during 2016 or 2015. The Company’s financial instruments consist primarily of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and accrued liabilities, debt instruments and derivative liabilities. For accounts receivable, accounts payable and accrued liabilities, the carrying amounts of these financial instruments as of September 30, 2016 and December 31, 2015 were considered representative of their fair values due to their short term to maturity. Cash equivalents are carried at cost which approximates their fair value. The fair value of the Term Loan and WCAS note approximate their carrying value as of September 30, 2016 and December 31, 2015.

 

The following tables set forth the Company’s financial assets and liabilities that were measured at fair value on a recurring basis as of September 30, 2016. No financial assets or liabilities were measured at fair value on a recurring basis at December 31, 2015.

 

     Fair Value as of September 30, 2016  
(Dollars in thousands)    Total      Level 1      Level 2      Level 3  

Derivative Liability - Warrant

   $ 335       $ —        $ —        $ 335   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 335       $ —        $ —        $ 335   
  

 

 

    

 

 

    

 

 

    

 

 

 

The Company’s derivative liabilities are classified within Level 3 because they are valued with an option pricing model, where certain inputs to the model are unobservable and reflect the Company’s assumptions as to what market participants would use.

The warrants were valued using the Black Scholes option pricing model (refer to note 9). The life of the warrant is equal to the weighted average remaining contractual life of the warrants. The volatility utilized is based upon the volatilities observed from publicly traded companies that are comparable to the Company. To date, the Company has not declared or paid dividends to any of its shareholders so the assumed dividend rate is zero. The short term risk-free rate utilized is the yield on US Treasury STRIPS corresponding to the life of the warrant.

The following table presents the Company’s liabilities measured at fair value using significant unobservable inputs (Level 3), as of September 30, 2016:

 

(Dollars in Thousands)       

Balance, December 31, 2015

   $ —    

Issuance of private company Series AB preferred warrant

     4,000   

Increase for fair value adjustment of warrant liability

     662   

Decrease for fair value adjustment of exercised warrant

     (1,557 ) 

Cancelled warrants

     (3,036 ) 

Issuance of common stock warrant in PPO

     266   
  

 

 

 

Balance, September 30, 2016

     335   
  

 

 

 

Concurrent with the closing of the 2016 Merger on May 3, 2016, the Company restructured its Term Loan and WCAS Note that extended the payment term of respective principal balance of $50 million and $5 million to March 31, 2021 and September 8, 2021. All warrants for private company common stock, Series D and private company Series AB there were outstanding on May 3, 2016 were cancelled.